Prophecy Emergency Department Registered Nurse (RN) Practice Test

The administration of tissue plasminogen activator (tPA) is critical in the management of acute ischemic strokes, as it can significantly improve outcomes if given within the appropriate time frame. The correct answer, which indicates that tPA should be administered within 3-4.5 hours of symptom onset, reflects current clinical guidelines and evidence-based practices. This time window is crucial because the effectiveness of tPA in dissolving the blood clot that is obstructing blood flow to the brain diminishes beyond this period. Administration within this time frame allows for a greater chance of reducing the severity of the stroke and decreasing potential disabilities associated with it. The decision to use tPA also considers factors such as patient eligibility and assessment of symptoms to ensure optimal treatment. Longer intervals past the 4.5-hour mark increase the risk of hemorrhagic transformation and other complications, which is why it is essential to adhere strictly to this timeline for administering tPA. Awareness of this time frame is vital for emergency nurses and healthcare providers in order to deliver timely and appropriate care to stroke patients.